136 related articles for article (PubMed ID: 29361659)
1. Associations between Bethesda categories and tumor characteristics of conventional papillary thyroid carcinoma.
Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ
Ultrasonography; 2018 Oct; 37(4):323-329. PubMed ID: 29361659
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of the Bethesda System for conventional papillary thyroid carcinoma.
Gweon HM; Koo HR; Son EJ; Kim JA; Youk JH; Hong SW; Lim BJ
Head Neck; 2016 Oct; 38(10):1509-14. PubMed ID: 27062195
[TBL] [Abstract][Full Text] [Related]
3. Association between Bethesda Categories and Ultrasound Features of Conventional Papillary Thyroid Carcinoma.
Kim GR; Kim EK; Kwak JY; Yoon JH; Moon HJ
Ultrasound Med Biol; 2016 May; 42(5):1066-74. PubMed ID: 26895756
[TBL] [Abstract][Full Text] [Related]
4. Does bethesda category predict aggressive features in malignant thyroid nodules?
Kleiman DA; Beninato T; Soni A; Shou Y; Zarnegar R; Fahey TJ
Ann Surg Oncol; 2013 Oct; 20(11):3484-90. PubMed ID: 23812773
[TBL] [Abstract][Full Text] [Related]
5. The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine-Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment.
Zha X; Miao Z; Huang X; Wang X; Xie R; Jin J; Zou D; Yang P; Huang Y
Front Endocrinol (Lausanne); 2022; 13():822423. PubMed ID: 35197932
[TBL] [Abstract][Full Text] [Related]
6. Non-papillary thyroid carcinoma diagnoses in The Bethesda System for Reporting Thyroid Cytopathology categories V and VI: An institutional experience.
Kang M; Kim NR; Seok JY
Ann Diagn Pathol; 2023 Dec; 71():152263. PubMed ID: 38195259
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
Wright K; Brandler TC; Fisher JC; Rothberger GD; Givi B; Prescott J; Suh I; Patel KN
Surgery; 2023 Jan; 173(1):239-245. PubMed ID: 36511283
[TBL] [Abstract][Full Text] [Related]
8. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
Al-Salam S; Sharma C; Abu Sa'a MT; Afandi B; Aldahmani KM; Al Dhaheri A; Yahya H; Al Naqbi D; Al Zuraiqi E; Mohamed BK; Almansoori SA; Al Zaabi M; Al Derei A; Al Shamsi A; Kaabi JA
PLoS One; 2021; 16(4):e0247807. PubMed ID: 33826647
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
Schumm MA; Shu ML; Hughes EG; Nikiforov YE; Nikiforova MN; Wald AI; Lechner MG; Tseng CH; Sajed DP; Wu JX; Yeh MW; Livhits MJ
JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):735-742. PubMed ID: 37382944
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Fine Needle Aspiration, the Bethesda System, and the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Association and Prediction for Biopsy.
Galán-García ME; Martínez-Martin MS; Araujo-Ruano EJ; Loro-Ferrer JF; Saavedra-Santana P; Salido-Ruiz E; Cabrera-Galván JJ
Acta Cytol; 2023; 67(4):346-356. PubMed ID: 36592623
[TBL] [Abstract][Full Text] [Related]
12. Using Ultrasonography to Evaluate the Relationship between Capsular Invasion or Extracapsular Extension and Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiao WP; Zhang L
Chin Med J (Engl); 2017 Jun; 130(11):1309-1313. PubMed ID: 28524830
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
[TBL] [Abstract][Full Text] [Related]
14. Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology.
VanderLaan PA; Marqusee E; Krane JF
Cancer Cytopathol; 2012 Aug; 120(4):245-53. PubMed ID: 22434789
[TBL] [Abstract][Full Text] [Related]
15. The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology.
Croce L; Teliti M; Chytiris S; Sparano C; Coperchini F; Villani L; Calì B; Petrone L; Magri F; Trimboli P; Rotondi M
Eur J Endocrinol; 2024 Feb; 190(2):165-172. PubMed ID: 38298148
[TBL] [Abstract][Full Text] [Related]
16. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
17. Impact of Ultrasonographic Features for Thyroid Malignancy in Patients With Bethesda Categories III, IV, and V: A Retrospective Observational Study in a Tertiary Center.
Hacim NA; Akbaş A; Ulgen Y; Aktokmakyan TV; Meric S; Tokocin M; Karabay O; Altinel Y
Cureus; 2021 Jul; 13(7):e16708. PubMed ID: 34466333
[TBL] [Abstract][Full Text] [Related]
18. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature.
Alshaikh S; Harb Z; Aljufairi E; Almahari SA
Cytojournal; 2018; 15():4. PubMed ID: 29531571
[TBL] [Abstract][Full Text] [Related]
19. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
[TBL] [Abstract][Full Text] [Related]
20. Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.
Gokozan HN; Dilcher TL; Alperstein SA; Qiu Y; Mostyka M; Scognamiglio T; Solomon JP; Song W; Rennert H; Beg S; Stern E; Goyal A; Siddiqui MT; Heymann JJ
Cancer Cytopathol; 2022 Apr; 130(4):259-274. PubMed ID: 34962713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
